ABSTRACT
Maximization of knowledge gained during the drug development process with the intent of increasing the probability of “success” in a clinical trial has received considerable attention recently (1). Clinical trial simulation has been recognized as being potentially useful for streamlining clinical drug development and evaluation with a view to maximizing information content of clinical trials (2-5).
